Clinical Trial Update: Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III) [Phase 3]

View source ↗

Summary

A multicenter, randomized Phase III trial evaluating short-course radiotherapy followed by Cadonilimab plus MFOLFOX6 as neoadjuvant therapy for locally advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cadonilimab
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Wan He | Conditions: Rectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING